Sign in

CIK 0001638287

  • Non-accelerated filer
  • Smaller reporting company

MetaVia Inc.

Sign in to watch
Ticker
MTVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472389984
Phone
+1 857-702-9600
Business address
545 CONCORD AVENUE, SUITE 210, CAMBRIDGE, MA, 02138
Former names
NeuroBo Pharmaceuticals, Inc., Gemphire Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-08-10 KOUSKY KENNETH W Director Conversion · 8% Convertible Subordinated Promissory Notes −0 0
2016-08-10 Gullans Steven R. Ph.D. Director Conversion +306,025 $6.71 $2.1M 306,025
2016-08-10 Gullans Steven R. Ph.D. Director Purchase +500,000 $10.00 $5.0M 806,025
2016-08-10 Gullans Steven R. Ph.D. Director Conversion · 8% Convertible Subordinated Promissory Note −0 0
2016-08-10 Reno Seth Chief Commercial Officer Purchase +4,000 $10.00 $40K 4,000
2016-08-10 Sooch Mina President & CEO Conversion +11,078 11,078
2016-08-10 Sooch Mina President & CEO Other acquisition +1,212 $6.71 $8K 12,290
2016-08-10 Sooch Mina President & CEO Conversion +27,141 $6.71 $182K 39,431
2016-08-10 Sooch Mina President & CEO Purchase +52,500 $10.00 $525K 693,732
2016-08-10 Sooch Mina President & CEO Conversion · Series A Convertible Preferred Stock −11,078 0
2016-08-10 Sooch Mina President & CEO Conversion · 8% Convertible Subordinated Promissory Notes −0 0
2016-08-10 Oniciu Carmen Daniela Vice President Conversion +2,237 152,156
2016-08-10 Oniciu Carmen Daniela Vice President Other acquisition +245 $6.71 $2K 152,401
2016-08-10 Oniciu Carmen Daniela Vice President Conversion · Series A Convertible Preferred Stock −2,237 0
2016-08-10 Lowenschuss David Chief Legal Off. & Secretary Purchase +11,120 $10.00 $111K 806,247
2016-08-10 MATHIESEN JEFFREY S Chief Financial Officer Conversion +3,927 $6.71 $26K 3,927
2016-08-10 MATHIESEN JEFFREY S Chief Financial Officer Purchase +4,000 $10.00 $40K 7,927
2016-08-10 MATHIESEN JEFFREY S Chief Financial Officer Conversion · 8% Convertible Subordinated Promissory Note −0 0
2016-08-10 Bisgaier Charles PhD Chair & Chief Scientific Off. Conversion +59,561 59,561
2016-08-10 Bisgaier Charles PhD Chair & Chief Scientific Off. Other acquisition +6,515 $6.71 $44K 66,076

Page 8 of 9 · 177 trades